MingMed Biotechnology Co., Ltd.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
The World First Liquid Formulation of Recombinant Botulinum Toxin Type A Has Obtained IND Approval by the FDA 2024-09-25 21:18
MingMed to Present at the 40th Annual J.P. Morgan Healthcare Conference 2022-01-06 09:00
1